Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity?
Publication
, Journal Article
Becker, RC; Ortel, TL
Published in: JAMA Intern Med
June 1, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
June 1, 2023
Volume
183
Issue
6
Start / End Page
532 / 533
Location
United States
Related Subject Headings
- SARS-CoV-2
- Humans
- COVID-19
- Blood Coagulation
- Anticoagulants
- 4203 Health services and systems
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C., & Ortel, T. L. (2023). Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity? JAMA Intern Med, 183(6), 532–533. https://doi.org/10.1001/jamainternmed.2023.0625
Becker, Richard C., and Thomas L. Ortel. “Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity?” JAMA Intern Med 183, no. 6 (June 1, 2023): 532–33. https://doi.org/10.1001/jamainternmed.2023.0625.
Becker RC, Ortel TL. Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity? JAMA Intern Med. 2023 Jun 1;183(6):532–3.
Becker, Richard C., and Thomas L. Ortel. “Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity?” JAMA Intern Med, vol. 183, no. 6, June 2023, pp. 532–33. Pubmed, doi:10.1001/jamainternmed.2023.0625.
Becker RC, Ortel TL. Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity? JAMA Intern Med. 2023 Jun 1;183(6):532–533.
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
June 1, 2023
Volume
183
Issue
6
Start / End Page
532 / 533
Location
United States
Related Subject Headings
- SARS-CoV-2
- Humans
- COVID-19
- Blood Coagulation
- Anticoagulants
- 4203 Health services and systems
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences